Trial Profile
Effect of perampanel in patients with drug-resistant epilepsy with low- and high-grade gliomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2017
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 28 Jul 2017 New trial record
- 27 Jun 2017 Results presented at the 3rd Congress of the European Academy of Neurology